Phase II trial of gemcitabine (2,2?-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas-Reference-Cited by-同舟云学术

Phase II trial of gemcitabine (2,2?-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Published:1994 Issue:1 Volume:12 Page:29-34
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Casper Ephraim S.,Green Mark R.,Kelsen David P.,Heelan Robert T.,Brown Thomas D.,Flombaum Carlos D.,Trochanowski Bonnie,Tarassoff Peter G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00873232.pdf

Reference14 articles.

1. Boring CC, Squires TS, Long T: Cancer Statistics. CA 41:19?36, 1991

2. Brennan MF, Kinsella T, Friedman M: Cancer of the Pancreas. In: Debita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology. 3rd edition. Philadelphia: JB Lippincott Company, 800?835, 1989

3. Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, Grindey GB: Evaluation of the antitumor activity of gemcitabine (2?,2?-difluoro-2?-deoxycytidine). Cancer Res 50:4417?4422, 1990

4. Heinemann V, Hertel L, Grindey GB, Plunkett W: Comparison of the cellular pharmacokinetics and toxicity of 2?,2?-difluorodeoxycytidine and 1-ß-D-arabinofuranosylcytosine. Cancer Res 48:4024?4031, 1988

5. Ghandi V, Plunkett W: Modulatory acitivity of 2?,2?-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res 50:3675?3680, 1990

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer drugs and acute kidney injury: new therapies and new challenges;Current Opinion in Nephrology & Hypertension;2024-05-07

2. Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy;Nature Cancer;2024-01-24

3. Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial;Journal of Clinical Oncology;2023-12-20

4. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma;Cancers;2023-08-25

5. New therapy for pancreatic cancer based on extracellular vesicles;Biomedicine & Pharmacotherapy;2023-06